Steven K Galson

BCRX

Steven K Galson serves as Director at BioCryst Pharmaceuticals, Inc. (BCRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$120.5K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$120.5K

Companies Traded

BCRX

Active Period

May 2024

1 total trades

Most Recent

Buy BCRX

May 13, 2024 · $120.5K

Steven K Galson's Insider Trading at BioCryst Pharmaceuticals, Inc. (BCRX)

Buys

1 · $120.5K

Sells

0 · $0.00

Total Shares Bought

21,940

Total Shares Sold

BCRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 13, 2024	Buy	21,940	$5.49	$120.5K	0

Related Insiders

Alane P Barnes

officer: Chief Legal Officer

BCRXSell · Mar 18, 2026

Charles K Gayer

President and CCO

BCRXSell · Dec 19, 2025

Jon P Stonehouse

Chief Executive Officer

BCRXSell · Dec 19, 2025

SANDERS MACHELLE

Director

BCRXSell · Nov 13, 2025

HEGGIE THERESA

Director

BCRXSell · Aug 13, 2025

Helen M. Thackray

Chief R&D Officer

BCRXSell · Mar 31, 2025

Explore More Insider Trading Data

BCRX Insider Trading Activity

View all insider trades at BioCryst Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity